Publication | Open Access

Assessment of SARS-CoV-2 serological tests for the diagnosis of COVID-19 through the evaluation of three immunoassays: Two automated immunoassays (Euroimmun and Abbott) and one rapid lateral flow immunoassay (NG Biotech)

Viral DiagnosticsMedicineDiagnostic TestCovid-19 PandemicImmunologySerologic TestingVirologyCovid-19 EpidemiologyPublic HealthSars-cov-2 Serological TestsEpidemiologyNg BiotechCovid-19